Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands

Cancer Cell

Volumn 6, Issue 3, 2004, Pages 275-284

  Arap, Marco A ^a   Lahdenranta, Johanna ^a   Mintz, Paul J ^a   Hajitou, Amin ^a   Sarkis, Álvaro S ^b   Arap, Wadih ^a   Pasqualini, Renata ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; GLUCOSE REGULATED PROTEIN 78; LIGAND;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIOPHAGE; CELL SPECIFICITY; CELL SURFACE; CHIMERA; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; STRESS;

ANIMALIA;

EID: 4544255170     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.08.018     Document Type: Article

References (45)

1. Adams G.P., Schier R., Marshall K., Wolf E.J., McCall A.M., Marks J.D., Weiner L.M. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies. Cancer Res. 58:1998;485-490
2. Arap W., Pasqualini R., Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:1998;377-380
3. Arap W., Kolonin M.G., Trepel M., Lahdenranta J., Cardó-Vila M., Giordano R.J., Mintz P.J., Ardelt P.U., Yao V.J., Vidal C.I., et al. Steps toward mapping the human vasculature by phage display. Nat. Med. 8:2002;121-127. a
4. Arap W., Haedicke W., Bernasconi M., Kain R., Rajotte D., Krajewski S., Ellerby H.M., Bredesen D.E., Pasqualini R., Ruoslahti E. Targeting the prostate for destruction through a vascular address. Proc. Natl. Acad. Sci. USA. 99:2002;1527-1531. b
5. Beere H.M., Wolf B.B., Cain K., Mosser D.D., Mahboubi A., Kuwana T., Tailor P., Morimoto R.I., Cohen G.M., Green D.R. Heat-shock protein inhibits apoptosis by preventing recruitment of procaspase-9 to the apaf-1 apoptosome. Nat. Cell Biol. 2:2000;469-475
6. Blond-Elguindi S., Cwirla S.E., Dower W.J., Lipshutz R.J., Sprang S.R., Sambrook J.F., Gething M.J. Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell. 75:1993;717-728
7. Cornford P.A., Dodson A.R., Parsons K.F., Desmond A.D., Woolfenden A., Fordham M., Neoptolemos J.P., Ke Y., Foster C.S. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res. 60:2000;7099-7105
8. Deroanne C.F., Hajitou A., Calberg-Bacq C.M., Nusgens B.V., Lapiere C.M. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Cancer Res. 50:1997;5531-5536
9. Dong D., Dubeau L., Bading J., Nguyen K., Luna M., Yu H., Gazit-Bornstein G., Gordon E.M., Gomer C., Hall F.L., et al. Spontaneous and controllable activation of suicide gene expression driven by the stress-induced Grp78 promoter resulting in eradication of sizable human tumors. Hum. Gene Ther. 15:2004;553-561
10. Ellerby H.M., Arap W., Ellerby L.M., Kain R., Andrusiak R., Rio G.D., Krajewski S., Lombardo C.R., Rao R., Ruoslahti E., et al. Anti-cancer activity of targeted proapoptotic peptides. Nat. Med. 5:1999;1032-1038
11. Giordano R.J., Cardó-Vila M., Lahdenranta J., Pasqualini R., Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat. Med. 7:2001;1249-1253
12. Hajitou A., Souni N.E., Devy L., Debrus-Grignet C., Lewalle J.M., Hong L., Deroanne C.F., Lu H., Colige A., Nusgens B.V., et al. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2. effect on in vivo mammary tumor growth and angiogenesis Cancer Res. 61:2001;3450-3457
13. Hajitou A., Grignet C., Devy L., Berndt S., Blacher S., Deroanne C.F., Bajou K., Fong T., Chiang Y., Foidart J.M., et al. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. FASEB J. 16:2002;1802-1804
14. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., Jain R.K., McDonald D.M. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156:2000;1363-1380
15. Jamora C., Dennert G., Lee A.S. Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. Proc. Natl. Acad. Sci. USA. 93:1996;7690-7694
16. Javadpour M.M., Juban M.M., Lo W.C., Bishop S.M., Alberty J.B., Cowell S.M., Becker C.L., McLaughlin M.L. De novo antimicrobial peptides with low mammalian cell toxicity. J. Med. Chem. 39:1996;3107-3113
17. Kamal A., Thao L., Sensintaffar J., Zhang L., Boehm M.F., Fritz L.C., Burrows F.J. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature. 425:2003;407-410
18. Kanoh Y., Ohtani N., Mashiko T., Ohtani S., Nishikawa T., Egawa S., Baba S., Ohtani H. Levels of α2 macroglobulin can predict bone metastases in prostate cancer. Anticancer Res. 21:2001;551-556
19. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum. coordination of gene transcriptional and translational controls Genes Dev. 13:1999;1211-1233
20. Koivunen E., Arap W., Valtanen H., Rainisalo A., Medina O.P., Heikkila P., Kantor C., Gahmberg C.G., Salo T., Konttinen Y.T., et al. Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol. 17:1999;768-774
21. Kolonin M.G., Saha P.K., Chan L., Pasqualini R., Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 10:2004;625-632
22. Koong A.C., Chen E.Y., Lee A.S., Brown J.M., Giaccia A.J. Increased cytotoxicity of chronic hypoxic cells by molecular inhibition of GRP78 induction. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;661-666
23. Lebret T., Watson R.W., Fitzpatrick J.M. Heat shock proteins. their role in urological tumors J. Urol. 169:2003;338-346. a
24. Lebret T., Watson R.W., Molinie V., O'Neill A., Gabriel C., Fitzpatrick J.M., Botto H. Heat shock proteins HSP27, HSP60, HSP70, and HSP90. expression in bladder carcinoma Cancer. 98:2003;970-977. b
25. Lee A.S. The glucose-regulated proteins. stress induction and clinical applications Trends Biochem. Sci. 26:2001;504-510
26. Li L.J., Li X., Ferrario A., Rucker N., Liu E.S., Wong S., Gomer C.J., Lee A.S. Establishment of a Chinese hamster ovary cell line that expresses grp78 antisense transcripts and suppresses A23187 induction of both GRP78 and GRP94. J. Cell. Physiol. 153:1992;575-582
27. Liu C., Bhattacharjee G., Boisvert W., Dilley R., Edgington T. In vivo interrogation of the molecular display of atherosclerotic lesion surfaces. Am. J. Pathol. 163:2003;1859-1871
28. Marchiò S., Lahdenranta J., Schlingemann R.O., Valdembri D., Wesseling P., Arap M.A., Hajitou A., Ozawa M.G., Trepel M., Giordano R.J., et al. Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell. 5:2004;151-162
29. Mickey D.D., Stone K.R., Wunderli H., Mickey G.H., Vollmer R.T., Paulson D.F. Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res. 37:1977;4049-4058
30. Mintz P.J., Kim J., Do K.A., Wang X., Zinner R.G., Cristofanilli M., Arap M.A., Hong W.K., Troncoso P., Logothetis C.J., et al. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat. Biotechnol. 21:2003;57-63
31. Misra U.K., Gonzalez-Gronow M., Gawdi G., Hart J.P., Johnson C.E., Pizzo S.V. The role of Grp 78 in α2-macroglobulin-induced signal transduction. Evidence from RNA interference that the low-density lipoprotein receptor-related protein is associated with, but not necessary for, GRP 78-mediated signal transduction. J. Biol. Chem. 277:2002;42082-42087
32. Miyake H., Hara I., Arakawa S., Kamidono S. Stress protein GRP78 prevents apoptosis induced by calcium ionophore, ionomycin, but not by glycosylation inhibitor, tunicamycin, in human prostate cancer cells. J. Cell. Biochem. 77:2000;396-408
33. Neckers L., Lee Y.S. Cancer. the rules of attraction Nature. 425:2003;407-410
34. Nicchitta C.V. Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nat. Rev. Immunol. 3:2003;427-432
35. Pasqualini R., Arap W., Rajotte D., Ruoslahti E. In vivo selection of phage-display libraries. Barbas C.F. III, Burton D.R., Scott J.K., Silverman G.J. Phage Display. A Laboratory Manual. 2001;1-24 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
36. Ravagnan L., Gurbuxani S., Susin S.A., Maisse C., Daugas E., Zamzami N., Mak T., Jaattela M., Penninger J.M., Garrido C., et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 3:2001;839-843
37. Reddy R.K., Mao C., Baumeister P., Austin R.C., Kaufman R.J., Lee A.S. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors. role of ATP binding site in suppression of caspase-7 activation J. Biol. Chem. 278:2003;20915-20924
38. Schmid S.L., Carter L.L. ATP is required for receptor-mediated endocytosis in intact cells. J. Cell Biol. 111:1990;2307-2318
39. Shin B.K., Wang H., Yim A.M., Le Naour F., Brichory F., Jang J.H., Zhao R., Puravs E., Tra J., Michael C.W., et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 278:2003;7607-7616
40. Smith G.P., Scott J.K. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217:1993;228-257
41. Sugawara S., Takeda K., Lee A., Dennert G. Suppression of stress protein GRP78 induction in tumor B/C10ME eliminates resistance to cell mediated cytotoxicity. Cancer Res. 53:1993;6001-6005
42. Tarli L., Balza E., Viti F., Borsi L., Castellani P., Berndorff D., Dinkelborg L., Neri D., Zardi L. A high-affinity human antibody that targets tumoral blood vessels. Blood. 94:1999;192-198
43. Vidal C.I., Mintz P.J., Manenti L., Broaddus R., Lu K., Ellis L.M., Gershenson D.M., Giavazzi R., Liu J., Arap W., et al. An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients. Oncogene. in press:2004
44. Viti F., Tarli L., Giovannoni L., Zardi L., Neri D. Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis. Cancer Res. 59:1999;347-352
45. Zurita A.J., Troncoso P., Cardó-Vila M., Logothetis C.J., Pasqualini R., Arap W. Combinatorial screenings in patients. the interleukin-11 receptor α as a candidate target in the progression of human prostate cancer Cancer Res. 64:2004;435-439